MedTrace Logo

A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis

NCT02016885 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 198

Last updated 2021-08-25

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety and efficacy of glycopyrrolate compared to vehicle for the treatment of axillary hyperhidrosis.

Conditions

  • Hyperhidrosis

Interventions

DRUG

glycopyrrolate, 1.0%

glycopyrrolate Topical Wipes, 1.0%

DRUG

glycopyrrolate, 2.0%

glycopyrrolate Topical Wipes, 2.0%

DRUG

glycopyrrolate, 3.0%

glycopyrrolate Topical Wipes, 3.0%

DRUG

glycopyrrolate, 4.0%

glycopyrrolate Topical Wipes, 4.0%

OTHER

Vehicle

Vehicle Topical Wipes

Sponsors & Collaborators

  • Journey Medical Corporation

    lead INDUSTRY

Principal Investigators

  • Lynne M Deans, MT · Dermira, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02016885 on ClinicalTrials.gov